PTPRC and neoplasm: While no CD45+ cells were detected in the healthy brain adjacent to the tumor (Supplementary Figure S7), very few CD45+ cells were found in the tumor-bearing animals that received the sham treatment or nivolumab only (Figure 6a,b, Supplementary Figure S8A).